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Background: The stromal-epithelial-cell interactions that are responsible for directing normal breast-tissue development
and maintenance play a central role in the progression of breast cancer. In the present study, we continued our
development of three-dimensional (3-D) cell co-cultures used to study cancerous mammary cell responses to
fractionated radiotherapy. In particular, we focused on the role of the reactive stroma in determining the therapeutic
ratio for post-surgical treatment.
Methods: Cancerous human mammary epithelial cells (MRC-7) were cultured in a 3-D collagen matrix with human
fibroblasts (MRC-5) stimulated by various concentrations of transforming growth factor beta 1 (TGF-β1). These culture
samples were designed to model the post-lumpectomy mammary stroma in the presence of residual cancer cells.
We tracked over time the changes in medium stiffness, fibroblast-cell activation (MRC-5 converted to cancer activated
fibroblasts (CAFs)), and proliferation of both cell types under a variety of fractionated radiotherapy protocols. Samples
were exposed to 6 MV X-rays from a linear accelerator in daily fraction sizes of 90, 180 and 360 cGy over five days in
a manner consistent with irradiation exposure during radiotherapy.
Results: We found in fractionation studies with MRC-5 fibroblasts and CAFs that higher doses per fraction may be
more effective early on in deactivating cancer-harboring cellular environments. Higher-dose fraction schemes inhibit
contractility in CAFs and prevent differentiation of fibroblasts, thereby metabolically uncoupling tumor cells from
their surrounding stroma. However, higher dose fraction appears to increase ECM stiffening.
Conclusions: The findings suggest that dose escalation to the region with residual disease can deactivate the
reactive stroma, thus minimizing the cancer promoting features of the cellular environment. Large-fraction irradiation
may be used to sterilize residual tumor cells and inhibit activation of intracellular transduction pathways that are
promoted during the post-surgical wound-healing period. The higher dose fractions may slow wound healing and
increase ECM stiffening that could stimulate proliferation of surviving cancer cells.
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There are several significant challenges to the successful
treatment of breast cancer in a heterogeneous patient
population. One primary challenge is the effective appli-
cation of adjuvant therapies to individuals; for example,
to determine the best fractionation schedules for minim-
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that stromal-epithelial cell signaling during wound heal-
ing plays an important role in answering that question
[1]. Heterotypic cell signaling is known to modulate the
formation and growth of tumors, and hence it can influ-
ence the radiosensitivity of residual cancer cells within
the reactive stroma microenvironment.
Properties of mesenchymal cells, the extracellular
matrix (ECM), and other insoluble proteins surrounding
cancer cells facilitate the production and storage of
growth factors that modulate the intensity of essential
cell signals. The stiffness of the ECM also directly influ-
ences cell behavior during tumor development via thearticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 MTT standard curves. Cells curves for monoculture cells
plated in a serial dilution ranging from 5000 to 120,000 cells/μl.
Samples were incubated for 4 h with MTT as described in Materials
and Methods. At the end of the MTT-incubation period, the formazan
crystals were dissolved in DMSO. During the experiment the formazan/
dimethyl sulphoxide solution was kept in the dark at room temperature.
In the range 10,000 and 30,000 cells/μl, the data indicate a linear
relationship between absorbance signal and cell number. Error bars
indicate one standard error of the mean (SEM)
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expression [2]. While it is difficult to untangle how these
myriad coupled signals are combined to promote or in-
hibit tumor growth, obtaining greater insights into this
complex process can help guide the design of safer and
more effective cancer treatments.
It is especially difficult to follow, in vivo, the multifac-
torial influences of cellular microenvironmental signal-
ing during a course of radiotherapy. So we abstracted
key elements of the post-surgical wound-healing micro-
environment in standard three dimensional (3-D) cell
cultures to isolate the most important influences. In this
report, we co-cultured cancerous epithelial cells (cancer
cells) with fibroblast cells in which some of the fibro-
blasts were prompted by growth factors to differentiate
into cancer-associated fibroblasts (CAFs). CAF pheno-
type was measured through the expression of α–SMA
using immunofluorescence staining. Under these condi-
tions fibroblasts are generally called carcinoma associ-
ated fibroblasts (CAFs) [3]. These co-culture samples
were designed to simulate features of the reactive stroma
within a surgical wound containing residual tumor cells.
The resulting data provides insights into the effects of
different microenvironmental conditions on the thera-
peutic ratio of fractionated radiotherapy.
The co-cultures used in this report expand the num-
ber of cellular influences that we assembled during a
previous study of the reactive stroma [4]. Culturing can-
cer cells with reactive stromal cells has allowed us to
observe the effects of heterotypic interactions on the
therapeutic ratio during treatment. The therapeutic ratio
is the kill rate of targeted cancer cells relative to that of
non-targeted cells for a given fractionation schedule. Of
course, co-cultures cannot include the entire range of
in vivo influences, especially important systemic factors
that mediate cell responses to radiotherapy. The input
parameters of this physical model are the initial numbers
of cells, the concentration of applied growth factors, and
fractionation parameters (timing and dose per fraction).
The output parameters of the model are the time-varying
numbers of each cell type (proliferation rates), fraction of
differentiated fibroblasts (fibroblast activation rate), and 3-
D collagen-matrix stiffness that describes the combined
effects of CAF contraction and radiation-induced collagen-
matrix cross linking. Study results may ultimately guide
the adjustment of fractionation parameters in patient
treatments by providing criteria for balancing cellular ra-
diosensitivity and sub-lethal damage repair rate while
maximizing patient tolerance.
To our knowledge, no systematic investigation involv-
ing co-culture models of residual disease in the post-
surgical environment has been conducted to observe
cancer cell behavior for different radiation fractionation
schedules. Studying how radiotherapy may influence therelease of stimulatory factors during wound healing might
also lead to the identification of new biomarkers for moni-
toring treatment responses. We hypothesize that 3-D cell
co-cultures, with an appropriate blend of environmental
influences, can provide predicative models for such inves-
tigations, where the goal is to deactivate cancer cells as
well as the reactive stroma so the latter does not act as a
promoter of the former. It seems possible to design a frac-
tionation prescription that is based on stromal biomarkers
and that eliminates all residual disease.
Results and discussion
Calibration of MTT absorbance measurements
Three cell types (MCF-7, MRC-5, and MRC-5 activated
by TGF-β1 to become CAF) underwent MTT assay ana-
lysis. All three cell types were plated into 96 well plates
individually in serial dilutions of cell density ranging
from 5000 – 120,000 cells/μl. To calibrate our system,
we first developed standard curves for each cell type, as
shown in Fig. 1. This was done by plating the full range
of cell densities in a 96-well plate and allowing time for
cell attachment but minimal propagation. We then
added the MTT assay reagent to measure the exact ab-
sorbance level of each well. The assay was allowed to in-
cubate for 4 h, before the medium was removed and the
dye was dissolved with 100 μl of DMSO. The optical
density was measured at 570 nm using a spectropho-
tometer to estimate absorbance.
The data in Fig. 1 indicate a logistic-curve relationship
between the absorbance signal and cell number. The ap-
pearance of the curve is explained from known cell behav-
iors at three density ranges. At the lowest cell densities
(<10,000 cells/μl), there is less direct contact among cells
and hence less of the paracrine signaling that enables
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suppressed. In the cell-density range of 10,000 - 30,000
cells/μl, MTT absorbance increases linearly with cell dens-
ity, which is expected if metabolic activity for all cells is
roughly equal. Cells are dense enough for the natural
paracrine signaling that enables normal metabolic activity.
When cell density is too high, cells quickly deplete vital
nutrients from the medium, which suppresses the average
metabolism per cell. Also at high densities, optical absorb-
ance can be above the operating range of 4 units where
the detector responds nonlinearly. Thus, in the range from
10,000 to 30,000 cells/μl, absorbance increased approxi-
mately linearly with cell density.
Once the linear range was established from the stand-
ard curves in Fig. 1, we chose a fixed cell density of
20,000 cells/μl to observe the metabolic changes in sam-
ples over 5 days. Unlike samples used in the standard
curve development, these cells proliferated during the 5-
day period. The absorbance values on days 0, 3 and 5
were measured and absorbance slope was used as the
relative metabolic activity. Figure 2 shows plots of ab-
sorbance for non-irradiated (control) MCF-7 cell sam-
ples and those irradiated at the 90 cGy fraction dose
conditions.
Absorbance as a measure of cell proliferation
Within the linear portion of the absorbance curve, ab-
sorbance measurements indicate relative cell number.
To establish the necessary relationship between MTT ab-
sorbance and cell number, we also manually counted cells
in confocal microscopy images of α-SMA, IF stained cell
samples. Clustering of MCF-7 cells made accurate cell
counting difficult. Instead, we measured the fractional area
occupied by cell clusters during the 5 day period and plot-
ted that area measurement versus absorbance. We foundFig. 2 MCF-7 metabolic activity. The MTT assay for MCF-7 cells under
irradiated and non-irradiated conditions for 2D monoculture. The
two data sets were fit to a straight line using linear regression.
Slopes indicate changes in the metabolism of cells in the sample
over time. A positive slope occurs during cell proliferation and a
negative slope occurs as the cancer cells respond to daily doses of
radiation. Error bars indicate one standard error of the mean (SEM)the linear functional relationship shown in Fig. 3, where
the correlation coefficient for the linear regression R2 =
0.9999. Assuming non-overlapping cells, constant meta-
bolic activity per cell, and absorbance in the linear range
of measurements, we established that absorbance is a pro-
portional to cell number. Hence absorbance rates indicate
relative cell proliferation rates.
Metabolic activity and cell type
Although the standard calibration curves for each cell
type in Fig. 1 are each linear over the same cell density
range, the slopes in that range are different indicating
different metabolic rates for each cell type. Specifically,
different cell types produce formazan at different rates,
which varies the slope of the absorbance curve. We no-
tice in particular that CAF appear to exhibit a higher
metabolic rate than non-activated MRC-5 fibroblasts for
the same number of cells. Also, unlike measurements
using IF stained images, the MTT assay naturally distin-
guishes between viable and dead cells.
Metabolic activity and IR fractionation
Figure 4 displays the change in metabolism measured
over five days (metabolic rate) for the three cell types
cultured independently. Samples were exposed at one of
three different dose fractions, and there were non-
irradiated control samples in each case. A rate listed as
zero indicates no change in cellular metabolism of a
sample from the initial value measured on day 0. Mea-
surements on control samples for all three cell types
(Fig. 4a-c) are positive, indicating an increase in overall
metabolism for cells in these samples over five days. We
interpret a positive rate as cell proliferation for the rea-
sons discussed above.
The MCF-7 (cancerous epithelial) cells have the high-
est control (non-irradiated) metabolism. They also have
the greatest sensitivity to radiation. Specifically, higher
dose fractions induce a greater reduction in the meta-
bolic activity of a sample compared with the other two
cell types. The reduction can be due to combinations of
cell death and reduced metabolic activity in surviving
cells, but we assume the change is dominated by cell
death. We see in Fig. 4a that the surviving fraction of
cells in irradiated samples was significantly lower than
that in the untreated controls, indicating, as expected,
that of the three types of cells MCF-7 are most sensitive
to radiation (overall p <0.05).
We also studied MRC-5 fibroblasts (Fig. 4b) under ex-
ogenous growth-factor free conditions and CAFs (Fig. 4c)
that were activated by exposing MRC-5 s to TGF-β1.
10 ng/ml TGF-β1(Sigma) in 0.5 % FBS/MEME. TGF-β1
was applied in a single treatment application prior to the
irradiation. We experimented with different TGF-β1 con-
centrations in the range of 0.10–10 ng/ml and measured
Fig. 3 Relationship between metabolic activity and surface area in MCF-7 cells. Absorbance from an MTT assay for a sample with an initial plating
density of 20,000 cells/μl. Absorbance was measured on days 0, 3, and 5 days for MCF-7 cells versus the area occupied by these cells at the same
times using IF stained images (INSET). Error bars indicate one standard error of the mean (SEM)
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blasts are more radio-resistant than MCF-7 cancer cells.
We found that CAFs are the most radio-resistant of the
three types.
We find that sample absorbance (and hence cell num-
ber) decreases with radiation dose just as others re-
ported [6]. If decisions on fractionation strategy are
based on the survival of cancer cells alone, the results of
Fig. 4a would suffice. The standard 180 cGy fraction
might be selected to save the patient some extra risk.
However, since the microenvironment also consists of
CAF whose population we also wish to minimize, Fig. 4c
shows that a standard fraction gives a relatively small
CAF response, and that the higher 360 cGy fraction
would be much more effective at reducing the CAF and
cancer cell populations provided that dose can be toler-
ated by the patient. Eliminating the CAF population
removes an important proliferative factor if there are re-
sidual cancer cells present in the stroma tissue of the
surgical wound. However, activated fibroblasts are also
important for the wound-healing process itself, and
therefore a higher fraction may slow the healing process.
Large fraction sizes have been proposed as a result of
the START trials [7] that favor use of hypofractionated
(i.e., larger fraction size) breast irradiation because it
provides excellent long-term local control and limited
late morbidity as well as benefits of convenience and
cost.
Stromal fibroblasts stimulate cancer cell growth
To characterize the behavior of cells in 3-D collagen co-
culture samples, MCF-7 cells were embedded in collagengels, with or without the addition of MRC-5 fibroblasts.
Based on preliminary studies, a 3:1 ratio was chosen of
MRC-5 to MCF-7 cells, respectively, to be used through-
out the investigation. Since the MTT assay provides in-
formation on total metabolic activity for a sample, we
detected the area of MCF-7 cells in a sample through
microscopy using IF staining in which MCF-7 and
MRC-5 fibroblast cells can be easily identified, counted,
and measured.
Mixing MRC-5 fibroblasts with MCF-7 cancer cells in
co-cultures further stimulated MCF-7 cell growth, as ex-
pected, resulting in larger and more abundant MCF-7
cell clusters (Fig. 5). MCF-7 cell clusters composed of
one cell to more than a hundred cells were included in
the analysis. The increase in MCF-7 proliferation was
significant from day 3 onward (data not shown).
Co-culture responses to IR
Co-culture samples were exposed to 5 sequential daily
fractions of 90, 180 or 360 cGy/fraction, for a total dose
of 450, 900 and 1800 cGy. The numbers of cells on day
5 that resulted from proliferation and radiation treat-
ments are illustrated in Fig. 5. MCF-7 cluster area was
reduced monotonically with fraction size. Exposed to the
same amounts of radiation, the average MCF-7 area was
larger in co-cultures than monocultures, though the dif-
ference was not significant at p = 0.05. The largest frac-
tion size of 360 cGy produced disproportionately more
damage than smaller fraction sizes (p < 0.05) in MCF-7
areas (Fig. 5). We believe these finds may demonstrate
the importance of regulating cancer cell survival and
proliferation during treatments.
Fig. 4 Change in metabolic acidity for dosing protocols. Metabolic
activity of MCF-7, MRC-5 and CAF cells measured over 5 days at
different dose fractions in 2D culture. a MCF-7 cancer cell metabolic
activity indicating radiation sensitivity. b MRC-5 metabolic activity and
c CAFs metabolic activity showing more radio-resistant behavior than
MRC-5 and MCF-7 cells. Error bars indicate one SEM. *indicates
statistical significance at the p < 0.05 level based on ANOVA analysis
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We went on to investigate another functional status of
irradiated cells – collagen matrix stiffness – which has
been shown to be a significant factor influencing tumor
cell invasiveness and angiogenesis [1,2]. MRC-5 fibro-
blasts in collagen were found in our previous study to
stiffen the collagen matrix somewhat. However, if we
add TGF-β1 that is known to transform MRC-5s into
CAFs, the collagen matrix stiffness more than doubled
the control value as the CAFs contract (Fig. 6). In one
set of samples, growth factors were not added to co-
cultures. Nevertheless, growth factors are produced by
cancer cells, and so it is not surprising that we see nearly
the same stiffening response as in equivalent co-culturesamples with growth factors added. Matrix stiffness values
were largest, in the range of 2.5 to 3 N/m for control sam-
ples when TGF β1 is present with fibroblasts.
Irradiating MRC-5 cells not exposed to growth factor,
we found matrix stiffness increased with dose, we believe
this may be due to production of reactive oxygen species
(ROS) as a result of the absorbed radiation induced cross
linking of the collagen matrix [8,9]. This mechanism in-
volves the activation of specific proteolytic enzymes from
inactive proenzymes and is most likely dependent on the
presence of reactive oxygen species (ROS). Scavengers of
radiation-induced free radicals or ROS, such as amifostine,
can inhibit ROS-induced activation of LTGFβ as well as
diminish the plasma level of TGF-β1 [10].
Irradiating co-cultures with TGF β1 at 90 cGy reduced
the stiffness of the collagen relative to the non-irradiated
samples but not as much as the reduction seen at the
180 cGy fraction. We believe the increase in stiffness
with the larger 360 cGy fraction indicates that ROS-
induced collagen cross linking is greater than CAF in-
activation. Overall, these results indicate that while CAF
appear to survive high radiation doses, their contraction
capacity may be considerably compromised.
Our data show that ionizing radiation generally re-
duces factors in the reactive stroma that contribute to
cancer cell proliferation. However excessive radiation
can stiffen the ECM that can promote proliferation of
surviving cancer cells.
Conclusions
We see our investigation as a first step in a new ap-
proach to radiotherapy planning involving the radiobiol-
ogy of cell cultures. In the past, radiobiology looked at
responses of cell types under isolated conditions. We
have begun to generalize these experimental conditions
to include 3-D co-culture models to evaluate the dose
fractionation schemes. However our studies have exam-
ined short-term effects, essentially those after 1 week of
treatment, when clinical goals are met only if disease
fails to recur after years, e.g., 5-years survival.
We maintain the radiobiological focus on cancer cell
responses but only for cells placed in a more natural
microenvironment, which acknowledges that the reactive
stroma is an important influence on both tumor recur-
rence and post-lumpectomy healing. So the feature space
of analysis is expanded to include fibroblast activation,
ECM stiffness, and CAF influences as well as cancer-cell
proliferation since each are important parameters influ-
encing the survival and phenotype of residual disease.
Myofibroblasts or CAFs have been found in a variety
of normal tissues and various pathological situations,
such as wound healing, fibromatosis, and stromal reac-
tion to epithelial tumors [11]. We found in fractionation
studies with MRC-5 fibroblasts and CAFs that higher
Fig. 5 MCF-7 cluster area at 5 days. MCF-7 cell cluster areas were measured after 5-days for control and irradiated samples and for mono- and
co-cultures. The presence of MRC-5 cells in the co-cultures induced MCF-7 cell growth, resulting in large, irregular, and partially branched epithelial cell
clusters. *indicates statistical significance at the p < 0.05 level based on ANOVA analysis
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activating cancer-harboring environments. Higher frac-
tion schemes inhibit contractility in CAFs and prevent
differentiation of fibroblasts, thereby metabolically un-
coupling tumor cells from their surrounding stroma.
Yet, over a time period longer than 5 days, the higher
dose fractions in patients may slow wound healing, and
the increase in ECM stiffening could stimulate any sur-
viving cancer cells.
The conclusion that MRC-5 fibroblasts definitively
modulated the response of MCF-7 cells to radiation re-
lies on two main considerations. First, using the MTT
assay on different cell types, CAFs were found to beFig. 6 Stiffness. Measurements of collagen matrix stiffness were
made after three days of culturing for samples formed with fibroblast
cells in co- and monocultures. This samples that were stimulated with
TFG-β1 and/or with radiation are indicated. Irradiated samples were
irradiated once each day at the daily dose indicated for three days.
Each bar indicates the average stiffness from one measurement taken
on each of 6 samples (mean ± 1 SE). *indicates statistical significance at
the p < 0.05 level based on ANOVA analysismost resistant to radiation in terms of metabolic activity,
i.e., for all fractionation schemes on days 3 and 5 (Fig. 3).
The observation that CAFs were more radio-resistant
and MCF-7 cells more radiosensitive suggested that the
target of interest should also include the CAFs cells.
These observations emphasize the metabolic cooper-
ation between residual cancer cells and newly formed
CAFs. Second, we saw that 3-D co-cultures of MCF-7
and MRC-5 cells produced significantly larger cancer-
cell clusters than that in samples containing MCF-7 cells
alone (Fig. 4). Taken together, these results suggest that
fibroblasts and cancer cells in co-culture become meta-
bolically coupled.
Many investigators have stressed the unique synergis-
tic characteristics between cancerous mammary epithelia
and CAF [12, 13]. In essence, together with the ECM,
these are the main components of stromatogenesis; i.e.,
the process of new stroma formation occurring concur-
rently with tumor cell invasion and angiogenesis. The
newly formed stroma not only provides tumor cells with
a substrate suitable for tumor cell growth and prolifera-
tion but also offers them metabolic support essential for
cancer cell survival. These findings direct attention to
the stromal components along with the tumor, which
might give rise to an improved therapeutic ratio.
Tumors are characterized by ECM remodeling and
stiffening [14]. Our experimental results both improve
our basic understanding of mechanobiology of the
microenvironment, metabolic activity, as well as identify
relevant therapeutic responses. Many investigators have
found breast cancer tissue to be as sensitive to fraction
size as dose-limiting healthy tissues [7, 15, 16]. Fibro-
blasts, CAFs and the factors they produce are important
targets for RT and prove to be useful prognostic markers.
These findings confirm that radiotherapy schedules can be
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entiation changes.
Expanding the study to include essential elements of
the tumor microenvironment provides new insights into
long term sustainability of tumor regeneration. Evalu-
ation of alternative fractionation techniques, e.g., hypo-
fractionation [7], may result in a useful alternative to
standard breast cancer RT for some patients. There is
value in a technique which reduces the treatment time
while maintaining cosmetic and functional control, if
adjusting fraction size from standard protocols does not
adversely affect stiffness or differentiation changes.
Methods
Cell lines and co-cultures
The human mammary carcinoma cell line MCF-7 and the
human lung fibroblast cell line MRC-5 were obtained
from the ATCC (Rockville, MD, USA). Collagen type I
stock solution (10 mg/ml, rat tail) were purchased from
BD Biosciences (Bedford, MA, USA); 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was
obtained from Sigma (St. Louis, MO, USA); Cell culture
media consisted of Dulbecco’s Modified Eagles Essential
Medium (DMEM, Invitrogen, Carlsbad, CA, USA) to
which 10 % fetal bovine serum (FBS, Sigma, St. Louis,
MO, USA) and 1 % pen/strep (P/S, Sigma, St. Louis, MO,
USA); Dimethylsulfoxide (DMSO) were purchased from
ATCC (Rockville, MD, USA); 48 and 96-well cell culture
clusters and other plastic disposables were purchased
from Corning Inc. (Corning, NY, USA). Transforming
growth factor beta 1 (TGF-β1) (Sigma, St. Louis, MO,
USA) was added to some cultures to transform a fraction
of the MRC-5 fibroblasts into cancer-associated fibro-
blasts (CAFs).
Type I collagen was selected as the 3-D scaffold for cell
culture because it resembles the extracellular matrix mi-
lieu of invasive breast carcinoma better than other poly-
mers. Collagen solutions were diluted from 10 mg/ml and
neutralized with DMEM medium and 1 N sodium hy-
droxide to 2.0 mg/ml. Cells were introduced to a particu-
lar sample at this time, before matrix polymerization.
600 μl volumes of collagen solution were dispensed to a
48-well plate and incubated at 37 °C as the collagen poly-
merized over 30 min. After polymerization, 300 μl of
complete DMEM was applied to the top of the gelled
samples. With or without cells, the total fluid volume
added to each sample was 600 μl so that matrix stiffness
was not influenced by medium volume.
Co-cultures were constructed by mixing 60,000 MCF-
7 epithelial cells and 200,000 MRC-5 fibroblast cells (1:3
ratio) into 600 μl of collagen matrix to mimic conditions
of residual disease in the post-surgical human breast.
Many researchers have used the 3/1 ratio breast cancer
cell lines (i.e. MCF-7) to fibroblast (i.e. MRC-5) to examinebreast cancer. However, we wanted to examine the post-
surgical environment, thus looking at the influence of a
microenivironment in a post-surgical region [17–20].
Values were chosen after evaluating the sustainability and
proliferation responses of cell samples. At higher initial
cell densities, MCF-7 cells proliferated continuously and
overtook samples. At lower initial cell densities, MCF-7
cells had difficulty sustaining growth. The initial density of
MRC-5 cells was optimized in our previous work for the
sample volume. The same initial cell densities were seeded
in samples where each cell type was cultured independ-
ently. Cultures were maintained for 5 days and the
medium was changed every 2–3 days.
Sample irradiation
Samples were irradiated by placing them in a 6 MV pho-
ton field generated by a linear accelerator (Varian Med-
ical System, Palo Alto, CA, USA) as described previously
[4]. Briefly, a uniform dose was delivered with the gantry
set to 0° and a 100 cm source-to-axis distance. An 8 ×
8 cm2 field size was selected to ensure cell-culture sam-
ples were uniformly irradiated. Dosimetric-quality solid
water was placed above and below the well plates to pro-
vide proper build-up dose. All samples were taken from
the incubator and placed in a thermally isolating con-
tainer for transportation to and from the clinic. Samples
were removed from the container, exposed to ionizing
radiation (IR) at room temperature in a single dose, and
returned to the incubator within 30 min. The standard
clinical dose fraction for breast treatment of 180 cGy
was delivered to samples at a rate of 400 cGy/min. Other
samples were exposed at the same dose rate but at a re-
duced fraction size of 90 cGy or an accelerated fraction
size of 360 cGy. All sample irradiations were delivered in
5 fractions, once each 24 h over 5 consecutive days, so
the total dose was 450, 900, or 1800 cGy. Dose delivery
verification was conducted following clinical standards.
MTT assays
In order to approximate the metabolic activity of irradi-
ated cells, the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphe-
nyltetrazolium bromide (MTT) assay was used. This
sensitive, quantitative and reliable assay measures the
conversion of MTT substrate produced in cells into a
formazan salt by cellular dehydrogenase [21]. MTT as-
sesses cellular metabolism based on the ability of the
mitochondrial succinate-tetrazolium reductase system to
convert the MTT into formazan. Viable cells reduce the
water-soluble yellow-colored MTT to a water-insoluble
purple colored formazan product in proportion to their
metabolic rate. The amount of colored formazan product
formed, as determined spectrophotometrically after dis-
solving the formazan crystals in DMSO, is proportional
to the net metabolic activity of cells with functioning
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mon tool used in radiobiological studies to assess meta-
bolic activity [17]. We applied it to in-vitro cell cultures
for the assessment of cellular metabolism, survival and
proliferation as described below.
We were unable to reliably use MTT assays in 3-D
cultures, so we performed 2-D culture studies to meas-
ure metabolic activity and 3-D cultures to measure cell
proliferation. Then we compared them to establish a
calibration in which either measurement described cell
proliferation.
Cells harvested from culture flasks by trypsinization
were resuspended in new phenol free media, plated at
different cell densities in 96-well culture plates, and in-
cubated at 37 °C in 5 % CO2. The cell medium was re-
placed every 2–3 days. The cell monolayer is treated for
4 h with MTT dissolved in PBS (concentration 5 mg/ml)
at 37 °C and 5 % CO2. After incubation, the MTT solu-
tion is removed and 100 μl DMSO is added to each well
of the 96-well plate to dissolve the formazan crystals.
Plates were shaken for 10 min to ensure adequate
solubilization. Assessment of metabolic activity was re-
corded as relative colorimetric changes measured at
570 nm. Samples were read in an Emax reader (Molecu-
lar Devices, Wokingham, UK) with Softmax PRO ver-
sion 4.3 software. Control-sample wells for absorbance
readings contained no cells or medium but MTT solu-
tion was added as per experimental wells on the plate.
They were removed after incubation and DMSO was
added. All experiments were performed at least 3 times
and the results were averaged.
Immunofluorescence staining (IF)
MRC-5 and MCF-7 cells were mixed in type I collagen
at a final collagen concentration of 2 mg/ml to form 3-D
co-cultures. Samples were maintained in DMEM con-
taining 10 % FBS and 1 % P/S at 37 °C in a humidified
atmosphere containing 5 % CO2. To quantify the cell
growth in collagen gel following mechanical testing, each
sample was washed with Phosphate-Buffered Saline
(PBS, Lonza, Wackersville, MD, USA) before being fixed
with 4 % paraformaldehyde at 4 °C overnight. Samples
were then washed and permeabilized in 0.02 % TritonFig. 7 Immunofluorescence staining of epithelial and fibroblast cell lines. Cell
into small spheroids. b MRC-5 cells appear distinct from each other with longX-100 in PBS for 15 mins followed by 5 % non-fat milk
blocking for 2 h. Gels were then incubated with primary
monoclonal α-SMA antibody, consisting of Bovine
Serum Albumin (BSA, Sigma), PBS and Tween 20 (T,
Sigma), (1:100 in 1 % BSA/PBS/T) overnight at 4 °C and
secondary antibody (1:200 in 1 % BSA/PBS/T) at room
temperature for 2 h. Cell nuclei were stained with TO-PRO
3 (1:1000 in PBS) for 20 mins. Sections were mounted
between two glass coverslips with anti-photobleaching
reagent.
Confocal microscopy
Immunofluorescence-stained 3-D cultures were exam-
ined with a Leica SP2 laser scanning confocal micro-
scope (Leica, Heidelberg, Germany) with Hg lamp,
helium/neon laser, and the associated software (Leica
Confocal Software Version 2.00). A 488 nm excitation
wavelength beam was applied for Fluorescein isothio-
cyanate (FITC) mapping, and a 633 nm excitation wave-
length beam was used to find cell nuclei via TO-PRO 3
mapping. For each sample, a 20X objective captured a
series of images along the z-coordinate (sample depth)
at 3–5 μm depth increments. We used a confocal mi-
croscopy system (Microradiance; Bio-Rad, Philadelphia,
PA, USA) consisting of a 25-Mw argon ion laser emit-
ting at 488 and 514 nm and a 1-Mw green helium–neon
laser emitting at 546 nm attached to a BX-50 micro-
scope (Olympus Imaging America, Inc., Center Valley,
PA, USA).
Automated area quantification for cell counting
MCF-7 cells were found to aggregate in clusters as cells
proliferated in the 3-D collagen matrix. Their cellular
morphology was obviously different from the MRC-5
cells, and so the two were easily distinguished. MCF-7
cells present relatively rounded and less spread morph-
ologies while the MRC-5 cells appeared as long-tailed
bodies expressing alpha-smooth muscle actin (α-SMA)
with distinct nuclei, as shown in Fig. 7. These imaging
techniques were used to quantify proliferation rates for
each cell type.
The numbers and areas of cells occupied by each type
were counted using automated segmentation softwarestaining was done with α-SMA a MCF-7 cells in monoculture clustered
-tail cell bodies and clearly identified nuclei. Scale bar = 200 μm
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croscope images (Qayyum and Kwak). To differentiate
MRC-5 and MCF-7 cells in co-culture samples, both
TO-PRO3 red and FITC green fluorescent (GF) images
were recorded and merged. In the MCF-7 cell growth
assay, a nucleus size exclusion strategy was applied dur-
ing the cell counting procedure. MRC-5 cells displayed a
more elongated nucleus than MCF-7 cells. We collected
the circular regions and then analyzed the MCF-7 cell
number and area. We calibrated the automated image
counting method with a hand counting method to valid-
ate accuracy. Coupling information from IF image ana-
lysis with MTT assays, we estimated viable cell numbers
during the five-day experiment to estimate cell prolifera-
tion rates.
Mechanical testing
The protocol for mechanical testing is detailed in our
previous work [4]. Briefly, samples were tested using a
TA.XT Plus Texture Analyzer System with a 1 kg load
cell (Texture Technologies Corp., Scarsdale, NY, USA)
and a compressive indentation procedure within 1 h fol-
lowing delivery of IR. The fluid medium was removed
from the top of the sample before testing with a 5-mm-
diameter spherical indenter. The indenter was pressed
into the sample surface under quasi-static conditions
(indenter velocity = 10−1 mm/min) and to a depth of
2.5 mm. Force (F) and displacement (d) were recorded
by the instrument to estimate sample stiffness. Force-
displacement plots show how force sensed by the in-
denter varied with indenter depth during loading and
unloading phases. Stiffness k is defined as the slope
F(d)/d near d = 0.
Statistical analysis
Analysis of variance (ANOVA) was performed using R
software to determine the significance of differences at
α = 0.05 level of significance. Observed differences among
mean sample groups were evaluated with post-hoc ana-
lysis, including Tukey HSD. This method was similar to
earlier publication [4].
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